MENU
+Compare
DGNOF
Stock ticker: OTC
AS OF
Feb 3 closing price
Price
$0.21
Change
-$0.06 (-22.22%)
Capitalization
21.6M

DGNOF Diagnos Inc. Forecast, Technical & Fundamental Analysis

Diagnos Inc is engaged in the provision of software-based interpretation services to assist health specialists in the detection of diabetic retinopathy... Show more

DGNOF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for DGNOF with price predictions
Feb 03, 2026

DGNOF in -2.80% downward trend, falling for three consecutive days on February 03, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where DGNOF declined for three days, in of 170 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for DGNOF moved out of overbought territory on January 07, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on January 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DGNOF as a result. In of 73 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for DGNOF turned negative on January 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at .

DGNOF moved below its 50-day moving average on January 16, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for DGNOF crossed bearishly below the 50-day moving average on January 23, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

The Aroon Indicator for DGNOF entered a downward trend on February 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 15 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

DGNOF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DGNOF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: DGNOF's P/B Ratio (108.696) is slightly higher than the industry average of (19.502). P/E Ratio (0.000) is within average values for comparable stocks, (99.648). DGNOF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.997). DGNOF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (357.143) is also within normal values, averaging (64.610).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DGNOF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.

View a ticker or compare two or three
DGNOF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry ServicestotheHealthIndustry

Profile
Fundamentals
Details
Industry
N/A
Address
7005 Taschereau Boulevard
Phone
+1 450 678-8882
Employees
42800
Web
http://www.diagnos.ca
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMROF0.250.03
+12.11%
AMAERO LTD.
ANZFF0.350.01
+2.83%
Air New Zealand Ltd.
ELEEF25.660.16
+0.63%
Element Fleet Mgmt Corp.
XRPN10.24N/A
N/A
Armada Acquisition Corp. II
BAYA11.85-0.02
-0.17%
Bayview Acquisition Corp

DGNOF and Stocks

Correlation & Price change

A.I.dvisor tells us that DGNOF and KNAMF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DGNOF and KNAMF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DGNOF
1D Price
Change %
DGNOF100%
-1.96%
KNAMF - DGNOF
27%
Poorly correlated
N/A
NEXOY - DGNOF
23%
Poorly correlated
-1.27%
NEXOF - DGNOF
20%
Poorly correlated
N/A
EBYH - DGNOF
10%
Poorly correlated
N/A
LFMD - DGNOF
6%
Poorly correlated
-3.05%
More

Groups containing DGNOF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DGNOF
1D Price
Change %
DGNOF100%
-1.96%
Services to the Health Industry
industry (92 stocks)
6%
Poorly correlated
-0.85%
Health Services
industry (410 stocks)
6%
Poorly correlated
-1.19%